MD4183B1 - Method for treatment of threatened preterm labor in monochorionic multiple pregnancy - Google Patents

Method for treatment of threatened preterm labor in monochorionic multiple pregnancy

Info

Publication number
MD4183B1
MD4183B1 MD20110030A MD20110030A MD4183B1 MD 4183 B1 MD4183 B1 MD 4183B1 MD 20110030 A MD20110030 A MD 20110030A MD 20110030 A MD20110030 A MD 20110030A MD 4183 B1 MD4183 B1 MD 4183B1
Authority
MD
Moldova
Prior art keywords
treatment
monochorionic
preterm labor
multiple pregnancy
threatened preterm
Prior art date
Application number
MD20110030A
Other languages
Moldavian (mo)
Romanian (ro)
Other versions
MD4183C1 (en
Inventor
George Paladi
Veaceslav MOSIN
Ludmila Tautu
Gheorghe Paladi
Original Assignee
Univ Nicolae Testemitanu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nicolae Testemitanu filed Critical Univ Nicolae Testemitanu
Priority to MDA20110030A priority Critical patent/MD4183C1/en
Publication of MD4183B1 publication Critical patent/MD4183B1/en
Publication of MD4183C1 publication Critical patent/MD4183C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine, in particular to obstetrics and gynecology and can be used for the treatment of threatened preterm labor in monochorionic multiple pregnancy.According to the invention, the method for treatment consists in that once a day, per os is administered micronized progesterone 200 mg or dydrogesterone 20 mg, or intramuscularly 1% oil solution of progesterone 1 ml, at the same time additionally per vaginum is administered micronized progesterone in the form of capsules 100 mg or 8% gel.
MDA20110030A 2011-03-30 2011-03-30 Method for treatment of threatened preterm labor in monochorionic multiple pregnancy MD4183C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20110030A MD4183C1 (en) 2011-03-30 2011-03-30 Method for treatment of threatened preterm labor in monochorionic multiple pregnancy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20110030A MD4183C1 (en) 2011-03-30 2011-03-30 Method for treatment of threatened preterm labor in monochorionic multiple pregnancy

Publications (2)

Publication Number Publication Date
MD4183B1 true MD4183B1 (en) 2012-10-31
MD4183C1 MD4183C1 (en) 2013-05-31

Family

ID=47136827

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20110030A MD4183C1 (en) 2011-03-30 2011-03-30 Method for treatment of threatened preterm labor in monochorionic multiple pregnancy

Country Status (1)

Country Link
MD (1) MD4183C1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895783A (en) * 1993-07-16 1999-04-20 Schering Aktiengesellschaft Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
RU2264213C1 (en) * 2004-04-30 2005-11-20 Абрамченко Валерий Васильевич Method of treating and preventing premature birth
MD335Z (en) * 2010-11-19 2011-10-31 Родика КАТРИНИЧ Method for preparing the neck of uterus for induction of delivery in pregnants with prolonged pregnancy

Also Published As

Publication number Publication date
MD4183C1 (en) 2013-05-31

Similar Documents

Publication Publication Date Title
MX2024010140A (en) Novel methods.
IN2014DN08088A (en)
WO2015085143A3 (en) Therapeutic agents for skin diseases and conditions
TN2015000007A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
JO3122B1 (en) Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicaments
MX2015013148A (en) Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics.
WO2016137164A3 (en) Composition including extracellular vesicles derived from bacteria of bacillus sp. for treating pregnancy-associated diseases
TN2013000533A1 (en) Topical ophthalmological pharmaceutical composition containing regorafenib
AU2018256668A1 (en) Combination therapy comprising an inhibitor of JAK, CDK and PIM
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
MY172530A (en) Method for treating gynecological diseases
MX2015007488A (en) Topical ophthalmological pharmaceutical composition containing regorafenib.
WO2015166419A3 (en) Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain
MD4183C1 (en) Method for treatment of threatened preterm labor in monochorionic multiple pregnancy
MX2015010594A (en) Lipobalanced long chain testosterone esters for oral delivery.
MD20140110A2 (en) Medicinal agent for the treatment of mastitis in bovine animals and preparation process thereof
MX2014014817A (en) Compounds for treating inflammation and pain.
NZ609804A (en) Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
RU2012114023A (en) METHOD FOR STIMULATING ENDOGENOUS PRODUCTION OF CYTOKINES AND HEMOPOETHIC FACTORS
MX2015004577A (en) Nutritional supplement for patients suffering from rheumatic diseases.
SG11201808241WA (en) Composition for skin moisturization or skin whitening, containing pentacyclic triterpene caffeic acid esters
MX2016006375A (en) A combination of dosage units for use in the treatment of pre-term labour condition.
Zhang Rash and fever: 2 case reports
Nayot Headache: 3 case reports
MD930Z (en) Method for treating genital herpes

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees